PEC12-25 CAPEC-PROCESS Industrial Consortium ... - DTU Orbit
PEC12-25 CAPEC-PROCESS Industrial Consortium ... - DTU Orbit
PEC12-25 CAPEC-PROCESS Industrial Consortium ... - DTU Orbit
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>CAPEC</strong>-<strong>PROCESS</strong><br />
3.4 External PhD-students (projects)<br />
Klaus Reinholdt Nyhuus<br />
Hansen (KRNH)<br />
<strong>DTU</strong> Management - <strong>CAPEC</strong><br />
satisfied product attributes is the main goal of this study. In<br />
order to achieve the objectives, four key tasks are needed.<br />
Firstly, the general chemical blending problem is formulated.<br />
Then, the property models are identified to estimate the pure and<br />
mixture properties. The unavailable property models are being<br />
developed by using experimental data and appropriate modeling<br />
tools. Next, the chemical mixture/blend algorithm is developed<br />
in order to find the best mixture/blend using suitable solution<br />
strategy. Finally, the developed mixture/blend algorithm is<br />
applied to case studies and validated with experimental data.<br />
Supervisors: RAG, JW, KVG<br />
Start: 01-06-2010; End: 01-05-2013<br />
Research area: A, B, C<br />
New product introduction for the pharmaceutical industry<br />
It is well known, that the pharmaceutical industry is struggling<br />
with increasing cost and length of R&D projects. Earnings of a<br />
drug drop drastically after patent expiration. Thus, the industry<br />
spends much effort on reducing Time-to-Market. However, a<br />
suitable methodology for planning operations immediately prior<br />
to launch is especially lacking.<br />
Due to strict cleaning requirements, production setups are very<br />
long. Production volumes are thus large and intermittent and the<br />
entire supply chain becomes rigid and inflexible. Besides<br />
forecast uncertainty, which is difficult for new products, other<br />
risks and uncertainties from carrying out reimbursement<br />
negotiations with authorities in each market e.g. reimbursement<br />
levels and product price can also disrupt the execution of a<br />
market launch.<br />
In this project a MILP-based methodology for planning<br />
operations before and during market launch is developed, which<br />
fits into the S&OP structure of pharmaceutical companies while<br />
considering risks and uncertainties. The methodology should be<br />
connected to the existing methodologies; pipeline planning,<br />
capacity planning and production planning.<br />
Supervisors: Renzo Akkerman (<strong>DTU</strong>-MAN); Martin Grunow;<br />
RaG<br />
Start: 01-09-2009; End: 31-08-2012<br />
Research area: D, E<br />
40